<DOC>
	<DOCNO>NCT00002353</DOCNO>
	<brief_summary>To evaluate HIV lipopeptide immunotherapeutic , P3C541b , two dose level administer subcutaneously HIV-seropositive patient .</brief_summary>
	<brief_title>A Phase I Safety Immunogenicity Trial UBI HIV Lipopeptide Immunotherapeutic P3C541b HIV-1 Seropositive Human Subjects</brief_title>
	<detailed_description>Patients randomize receive P3C541b placebo within two study group . Enrollment first group independent HLA type , whereas two patient enrol group 2 must one HLA type A33 , B8 , B27 , Bw62 . Treatment group 2 begin group 1 reach day 14 without serious toxicity .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV positivity . CD4 count &gt; = 500 cells/mm3 . No evidence AIDS , persistent diarrhea , fever , oral hairy leukoplakia , herpes varicellazoster ( multidermatomal ) , oral candidiasis , opportunistic infection , severe cytomegalovirus infection , disseminate chronic herpes simplex . Successful establishment EBV transform B lymphoblastoid cell line . NOTE : Most patient group 2 must possess one HLA type A33 , B8 , B27 , Bw62 . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Active syphilis . Positive circulate hepatitis B virus antigen . Active clinically significant medical problem . Evidence psychiatric , medical , substance abuse problem would affect ability participate study . Occupational responsibility would prevent completion study . Concurrent Medication : Excluded : Other HIV immunotherapeutic . Zidovudine analog . Investigational therapy HIV . Patients follow prior condition exclude : History cancer unless surgically excise reasonable assurance cure . History anaphylaxis serious adverse reaction vaccine . History serious allergic reaction substance require hospitalization emergent medical care ( e.g. , StevensJohnson syndrome , bronchospasm , hypotension ) . History autoimmune disease use immunosuppressive medication . History suicide attempt past psychosis . Prior Medication : Excluded within past 6 month : HIV immunotherapeutic . Zidovudine analog . Investigational therapy HIV . Illicit drug use within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 1997</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>AIDS Vaccines</keyword>
</DOC>